Single-Cell RNA Sequencing of Terminal Ileal Biopsies Identifies Signatures of Crohn's Disease Pathogenesis.
Monika Krzak,Tobi Alegbe,D Leland Taylor,Gareth-Rhys Jones,Mennatallah H Ghouraba,Michelle Strickland,Bradley T Harris,Reem Satti,Kenneth Arestang,Lucia Ramirez-Navarro,Nilanga Nishad,Kimberly Ai Xian Cheam,Tina Thompson,Moritz J Przybilla,Marcus Tutert,Matiss Ozols,Guillaume Noell,Steven Leonard,Velislava Petrova,Carla Jones-Bell,Noor Wana,May Xueqi Hu,Jason Skelton,Jasmin Ostermayer,Yong Gu,Claire Dawson,Wendy Garri,Brezina Biljana,Charry Queen Caballes,Daniele Corridoni,Miles Parkes,Vivek Iyer,Cristina Cotobal,Rebecca E McIntyre,Tim Raine,Carl A Anderson
DOI: https://doi.org/10.1101/2023.09.06.23295056
2024-12-17
Abstract:Crohn's disease (CD) is a chronic inflammatory bowel disease exhibiting substantial heterogeneity in clinical presentation and response to therapy. To explore its molecular basis, we developed IBDverse, the largest single-cell RNA sequencing (scRNA-seq) dataset of terminal ileal biopsies, profiling over 1.1 million cells from 111 CD patients and 232 healthy controls. This resource integrates discovery and replication cohorts for robust identification of CD-associated cell types, genes, and pathways. We uncovered epithelial changes marked by interferon-driven MHC-I upregulation, persisting in progenitors after macroscopic inflammation resolution. ITGA4+ macrophages were identified as key inflammatory drivers, showing enriched JAK/STAT signaling and cytokine expression (IL-6, IL-12, IL-23). Heritability analysis linked inflammatory monocytes and macrophages to CD susceptibility, implicating resident and recruited immune cells in pathogenesis. These findings establish a comprehensive cellular and molecular framework for CD, offering new insights into disease mechanisms and therapeutic opportunities.